“We’re investing in next-gen CDMO & peptide building blocks infrastructure to support the evolving demands of complex therapies.”
This week, SpeakPharma interviews Dr. Abdelaziz Toumi, Chief Executive Officer of Lupin Manufacturing Solutions (LMS). In this ...

